John B. Muggsy

Telling the truth by lying through my teeth

[johnbmuggsy]

Give the insufficient heart a hug, c/o @harvardmed @BostonChildrens #Innovation

https://goo.gl/fwiwsi

[johnbmuggsy]

ACA won’t just disappear. Tweaking to come…

[johnbmuggsy]

I am really glad that Jay Leno and Arnold Schwarzenegger are speaking at #Becker’s Hospital Conference. Serious illness needs to lighten up, right?. https://goo.gl/BZLuSx

[johnbmuggsy]

Feeling with "bionics"

#Prosthetics that feel? Pretty darn cool #medicalinnovation https://goo.gl/w4vHsI

[johnbmuggsy]

With all the corporate leaders on this list, hard to see where the innovation is coming from. https://m.dotmed.com/news/story/33322

[johnbmuggsy]

Nano Nobel

Very little to say on this. Almost nothing. https://www.google.com/amp/www.bbc.co.uk/news/amp/37486374?client=ms-android-verizon #nanohealth

[johnbmuggsy]

Age increases on hold?

Some researchers suggest we have reached the upper limit of life expectancy. Kind of like saying the Earth ends at the horizon. #Calico

http://www.theguardian.com/science/2016/oct/05/human-lifespan-has-hit-its-natural-limit-research-suggests?CMP=Share_AndroidApp_WordPress

[johnbmuggsy]

Cosgrove on innovation

#medicalinnovation https://www.linkedin.com/pulse/medical-innovation-rebirth-cities-toby-cosgrove?trk=hp-feed-article-title-publish

[johnbmuggsy]

Can dopamine antagonists treat pancreatic cancer? goo.gl/2o8bNV

[johnbmuggsy]

High level of disease and death for face transplant recipients. http://goo.gl/qWFdTB

[johnbmuggsy]

Cambridge Venture Fund aiming for IPO

Cambridge Venture Fund aiming for IPO http://www.cbronline.com/news/verticals/small-business/cambridge-university-startup-raises-75m-ahead-of-possible-ipo-4985387

[johnbmuggsy]

Bigger Moons is a boutique consultancy focused on marketing strategy, customer insight and brand development. Our focus is healthcare: pharmaceutical, biotechnology, medical device, diagnostic, health systems, and insurers.

Bigger Moons has significant expertise in a wide variety of therapeutic categories.

Our leadership team has worked inside some of the largest pharmaceutical companies, as well as for leading consultancies. It is comprised of marketing executives, statisticians, insights experts and project directors. We have consulted with most of the top 100 healthcare firms, as well as numerous emergent companies in the industry.

We are experienced in working with high-growth, early development companies. Our insights and strategy provide a realistic view of market opportunity, and how to present that opportunity to the marketplace. We approach our relationships with early-stage companies realistically, and provide them with products and services that are reasonably priced and rapidly executed.

We focus on the specifics of your product and its unique context, rather than trying to duplicate the less specific types of information available on the internet. We work with your profile to understand potential customers, achievable opportunities and possible threats.

[johnbmuggsy]

[johnbmuggsy]

Nanohealth - bacterial wires from the Navy

#Nanohealth – bacterial wires from the Navy http://goo.gl/UsOvhY

[johnbmuggsy]

Breakthrough: 55% of lipid carrying cells deliver treatment to hypoxic #cancer tumor zones. #nanomedicine

http://goo.gl/Wbw2ED

[johnbmuggsy]

The new frontier

Wearable tech in the gray space beyond privacy and personal freedom

http://www.medgadget.com/2016/08/battery-free-skin-sensors-run-wireless-energy-powered-smartphones.html

[johnbmuggsy]

Brigham & Women's CNO out

#Fired, by any other name, is still fired. #partners http://www.beckershospitalreview.com/hospital-executive-moves/brigham-and-women-s-hospital-cno-to-step-down-following-averted-strike.html